Munich - Delayed Quote EUR
Corcept Therapeutics Inc (HTD.MU)
As of 8:02 AM GMT+2. Market Open.
Key Executives
Key Executives Information Not Available
Corcept Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Corcept Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
October 30, 2024 at 10:59 AM UTC - November 4, 2024 at 12:00 PM UTC
Corcept Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
1VT.F Viking Therapeutics, Inc.
58.50
-1.18%
IVA.PA Inventiva S.A.
2.6350
+0.19%
SGMT Sagimet Biosciences Inc.
5.78
+3.66%
GMAB Genmab A/S
22.63
-0.66%
REGN Regeneron Pharmaceuticals, Inc.
959.81
-0.90%
NOVO-B.CO Novo Nordisk A/S
801.00
-0.82%
VRTX Vertex Pharmaceuticals Incorporated
475.05
-0.64%
MRNA Moderna, Inc.
53.03
-1.43%